Semba Charles Pauling 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 2, 2024
Insider Transaction Report
Form 4
Semba Charles Pauling
Director
Transactions
- Award
Voting Common Shares, no par value per share
2024-01-02$2.80/sh+9,375$26,250→ 39,318 total
Footnotes (2)
- [F1]These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.
- [F2]Includes 9,375 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.